Displaying 1051 - 1058 of 1058 results
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Acetylcysteine for the treatment of paracetamol overdose and toxicity – 2-bag dosing guidance
New dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity issued in January 2019.
-
Opioid implementation package
This package outlines the next steps and what the options are to make a significant difference in opioid-induced adverse drug events.
-
Safe use of opioids measurement: frequently asked questions
Frequently asked questions about measurement for the safe use of opioids.
-
Safe use of opioids collaborative information for DHB hospitals
Information document for DHBs about the breakthrough series collaborative on safe use of opioids in hospitals.
- Patient Safety Week 2019 | Understanding bias in health care
- Key findings: Diabetes Equity Explorer indicators
- Key findings: Gout Equity Explorer indicators